PCDH17 and urinary bladder cancer: p53 and PCDH17 were each significantly associated with survival from bladder cancer (p=0.038, p=0.031, p=0.031, Figure 2A, 2B, 2C), while low-expression of Beclin-1 just showed a trend towards patient survival (p=0.112, Figure 2D).